Lv32
220 积分 2024-01-11 加入
An interpretation of global consensus on the diagnosis and management of limbal stem cell deficiency
8天前
已完结
Human pluripotent stem cell-derived organoids repair damaged bowel in vivo
22天前
已完结
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus
1个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
1个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
1个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
1个月前
已完结
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co‐Expression Patterns: A Double‐Blind, Randomized, Placebo‐Controlled, Phase 2 Trial
1个月前
已完结
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
1个月前
已完结
Telitacicept: A novel horizon in targeting autoimmunity and rheumatic diseases
1个月前
已完结
Retinol binding protein 4 antagonists and protein synthesis inhibitors: Potential for therapeutic development
1个月前
已完结
皖公网安备34019202002308
